IP Library Assignment 053368/0577
Patent Assignment
Reel/Frame 053368/0577

Release of Security Interest

Recorded: 2020-07-31 Pages: 18
Assignor
OAKTREE FUND ADMINISTRATION, LLC
Executed: 2020-07-14
Assignees
SORRENTO THERAPEUTICS, INC.
4955 DIRECTORS PLACE, SAN DIEGO, CALIFORNIA, 92121
TNK THERAPEUTICS, INC.
4955 DIRECTORS PLACE, SAN DIEGO, CALIFORNIA, 92121
CONCORTIS BIOSYSTEMS, CORP.
4955 DIRECTORS PLACE, SAN DIEGO, CALIFORNIA, 92121
ARK ANIMAL HEALTH, INC.
4955 DIRECTORS PLACE, SAN DIEGO, CALIFORNIA, 92121
SCINTILLA PHARMACEUTICALS, INC.
4955 DIRECTORS PLACE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (105)
Novel Method for Cloning Variable Domain Sequences of Immunological Gene Repertoire
Patent: 7,405,062 →
Application: 10/477,907 →
Publication: US 2004/0157210
Transdermal Patch Containing Microneedles
Patent: 8,696,637 →
Application: 13/036,096 →
Publication: US 2012/0220980
Nanopatterned Medical Device with Enhanced Cellular Interaction
Application: 13/095,489 →
Publication: US 2011/0270221
Transdermal Device Containing Microneedles
Patent: 8,636,696 →
Application: 13/157,412 →
Publication: US 2012/0316503
Method for Increasing the Permeability of an Epithelial Barrier
Patent: 9,586,044 →
Application: 13/641,500 →
Publication: US 2013/0150822
Device for Delivery of Rheumatoid Arthritis Medication
Patent: 9,522,263 →
Application: 13/641,501 →
Publication: US 2013/0144257
MEDICAL DEVICES FOR DELIVERY OF siRNA
Patent: 9,522,262 →
Application: 13/641,502 →
Publication: US 2013/0158505
Composite Microneedle Array Including Nanostructures Thereon
Patent: 9,526,883 →
Application: 13/641,504 →
Publication: US 2013/0165861
Injection Molded Microneedle Array and Method for Forming the Microneedle Array
Patent: 9,545,507 →
Application: 13/641,507 →
Publication: US 2013/0144217
Fully Human Antibodies that Bind to VEGFR2 and Methods of Use Thereof
Patent: 9,029,510 →
Application: 13/854,071 →
Publication: US 2014/0294827
Antibodies that Bind Epidermal Growth Factor Receptor (EGFR)
Patent: 9,944,707 →
Application: 13/893,312 →
Publication: US 2013/0309233
Antigen Binding Proteins that Bind Delta-Like 4 (DLL-4)
Application: 13/903,793 →
Publication: US 2013/0323248
Antigen Binding Proteins That Bind Pd-L1
Patent: 9,175,082 →
Application: 13/907,685 →
Publication: US 2013/0323249
Antibodies Which Bind Insulin-Like Growth Factor Receptor-1 (IGF1R) and Methods of Use Thereof to Treat Cancer
Application: 13/916,129 →
Publication: US 2013/0344069
Antigen Binding Proteins That Bind C-Met
Application: 13/924,492 →
Publication: US 2017/0283501
Antigen Binding Proteins That Bind CCR2
Patent: 9,315,579 →
Application: 13/924,501 →
Publication: US 2013/0344070
Antigen Binding Proteins that Bind ErbB3
Patent: 9,346,890 →
Application: 14/061,548 →
Publication: US 2014/0120092
Anti-Infective Binding Proteins that Bind AIP2
Patent: 8,859,740 →
Application: 14/062,774 →
Publication: US 2014/0120093
Antigen Binding Proteins that Bind PD-1
Patent: 9,676,853 →
Application: 14/292,866 →
Publication: US 2014/0356363
Implantable Devices for Delivery of Bioactive Agents
Application: 14/354,223 →
Publication: US 2014/0287019
Transdermal Delivery of High Viscosity Bioactive Agents
Patent: 9,550,053 →
Application: 14/354,229 →
Publication: US 2014/0343532
Drug-Conjugates, Conjugation Methods, and Uses Thereof
Patent: 9,884,127 →
Application: 14/401,114 →
Publication: US 2015/0105539
Drug-Conjugates, Conjugation Methods, and Uses Thereof
Patent: 9,981,046 →
Application: 14/401,115 →
Publication: US 2016/0067350
Drug-Conjugates, Conjugation Methods, and Uses Thereof
Patent: 9,801,951 →
Application: 14/401,318 →
Publication: US 2015/0141646
Anti-Infective Binding Proteins that Bind AIP2
Patent: 9,631,009 →
Application: 14/473,916 →
Publication: US 2016/0060327
Fully Human Antibodies that Bind to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
Application: 14/680,865 →
Publication: US 2017/0166644
Drug Delivery Device
Patent: 9,861,801 →
Application: 14/762,534 →
Publication: US 2015/0360018
Transdermal Drug Delivery Device
Application: 14/762,844 →
Publication: US 2015/0367117
Microneedles With Improved Open Channel Cross-Sectional Geometries
Patent: 9,795,775 →
Application: 14/787,044 →
Publication: US 2016/0106965
Fully Human Anti-C-X-C Chemokine Receptor 3 (CXCR5) Antibodies
Patent: 9,765,145 →
Application: 14/821,559 →
Publication: US 2016/0053013
Fully Human Anti-CXC Chemokine Receptor 5 (CXCR5) Antibodies
Patent: 9,765,146 →
Application: 14/825,144 →
Publication: US 2016/0053014
Antibody Therapeutics That Bind Oprf
Patent: 9,879,069 →
Application: 14/839,791 →
Publication: US 2016/0060326
Draped Microneedle Array
Patent: 9,962,536 →
Application: 14/914,302 →
Publication: US 2017/0036005
Cartridge Portion of Transdermal Drug Delivery Apparatus and Methods
Application: 14/914,306 →
Publication: US 2017/0035652
Antibody Drug Conjugates
Application: 15/009,775 →
Publication: US 2017/0190736
Antibody Drug Conjugates
Application: 15/017,174 →
Publication: US 2017/0224835
Small Molecule C-Myc Inhibitors
Application: 15/035,842 →
Publication: US 2016/0264560
Antibody Therapeutics That Bind CTLA4
Application: 15/043,157 →
Publication: US 2016/0237154
Antibody Therapeutics That Bind CD137
Application: 15/049,718 →
Publication: US 2016/0244528
Antibody Therapeutics That Bind CD137
Application: 15/050,215 →
Publication: US 2017/0226215
Antibody Therapeutics That Bind CD47
Application: 15/061,771 →
Publication: US 2016/0257751
Antibody Therapeutics That Bind TIM3
Patent: 9,873,741 →
Application: 15/061,832 →
Publication: US 2016/0257758
Antibody Therapeutics That Bind JAG1
Application: 15/063,006 →
Publication: US 2016/0257759
Antibody Therapeutics That Bind Psma
Application: 15/066,806 →
Publication: US 2016/0326264
Antibody Therapeutics That Bind CD38
Patent: 9,951,144 →
Application: 15/093,773 →
Publication: US 2017/0291959
Antibody Therapeutics That Bind CD123
Application: 15/093,777 →
Publication: US 2017/0291949
Antibody Therapeutics That Bind CD123
Patent: 9,969,807 →
Application: 15/093,780 →
Publication: US 2016/0297882
Antibody Therapeutics That Bind CD38
Application: 15/094,384 →
Publication: US 2016/0297888
Antigen Binding Proteins that Bind CCR2
Patent: 9,951,138 →
Application: 15/097,955 →
Publication: US 2016/0289329
Antigen Binding Proteins that Bind ErbB3
Patent: 9,938,352 →
Application: 15/141,593 →
Publication: US 2016/0311923
Antibody Therapeutics That Bind LAG3
Patent: 9,902,772 →
Application: 15/217,238 →
Publication: US 2017/0022273
Intracellular Delivery Compounds
Application: 15/298,813 →
Publication: US 2017/0107289
Antibody Therapeutics That Bind CD147
Application: 15/304,358 →
Publication: US 2017/0037129
Transdermal Drug Delivery Apparatus and Methods
Application: 15/305,193 →
Publication: US 2017/0120025
Controller Portion of Transdermal Drug Delivery Apparatus and Methods
Application: 15/305,201 →
Publication: US 2017/0043146
Receptacle Portion of Transdermal Drug Delivery Apparatus and Methods
Application: 15/305,206 →
Publication: US 2017/0043148
Chemically-Locked Bispecific Antibodies
Application: 15/310,214 →
Publication: US 2017/0260291
Antigen Binding Proteins That Bind WISP1
Application: 15/330,956 →
Publication: US 2017/0304442
Programmable Universal Cell Receptors and Method of Using the Same
Application: 15/333,115 →
Publication: US 2017/0112878
Chemically-Locked Bispecific Antibodies
Application: 15/353,979 →
Publication: US 2017/0137539
Device for Delivery of Rheumatoid Arthritis Medication
Application: 15/378,097 →
Publication: US 2017/0157380
Medical Devices for Delivery of siRNA
Application: 15/378,109 →
Publication: US 2017/0157381
Composite Microneedle Array Including Nanostructures Thereon
Application: 15/382,774 →
Publication: US 2017/0143949
Safety for Treating Cancers with a Glycosylated Chimeric Antibody to EGFR
Application: 15/403,102 →
Publication: US 2017/0247458
Safety and Efficacy with a CHO Cell Glycosylated Chimeric Antibody to TNF
Application: 15/403,115 →
Publication: US 2017/0247443
Transdermal Delivery of High Viscosity Bioactive Agents
Application: 15/411,318 →
Publication: US 2017/0128707
Method for Increasing the Permeability of an Epithelial Barrier
Application: 15/413,475 →
Publication: US 2017/0151424
Antigen Binding Proteins That Bind Pd-L1
Application: 15/418,514 →
Publication: US 2017/0218066
Anti-Infective Binding Proteins That Bind AIP2
Application: 15/462,427 →
Publication: US 2018/0037638
Calicheamicin Antibody Drug Conjugates Linking an Amidoacetyl Group to a Sugar Moiety on Calicheamicin
Application: 15/472,965 →
Publication: US 2017/0281758
Antibody Therapeutics That Bind STAT3
Application: 15/496,994 →
Publication: US 2017/0306048
C-Met Antibody Drug Conjugate
Application: 15/533,360 →
Publication: US 2018/0280531
Antigen Binding Proteins That Bind Pd-1
Application: 15/589,051 →
Publication: US 2017/0313776
Antibody Drug Conjugates Having Derivatives of Amatoxin as the Drug
Application: 15/609,858 →
Publication: US 2017/0340750
Antigen Binding Proteins That Bind Pd-L1
Application: 15/619,389 →
Publication: US 2017/0281765
Methods for Treating Subjects Having a Cxc Chemokine Receptor 5 (CXCR5)-Responsive Cancer by Administering Fully Human Anti-CXCR5 Antibodies
Application: 15/674,401 →
Publication: US 2017/0342156
Drug-Conjugates, Conjugation Methods, and Uses Thereof
Application: 15/679,599 →
Publication: US 2018/0085471
Fully Human Anti-C-X-C Chemokine Receptor 3 (CXCR3) Antibodies
Application: 15/682,206 →
Publication: US 2019/0008955
Methods for Better Delivery of Active Agents to Tumors
Application: 15/744,346 →
Publication: US 2018/0193624
Methods for Lymphatic Delivery of Active Agents
Application: 15/744,385 →
Publication: US 2018/0193625
Antibody Therapeutics That Bind TIM3
Application: 15/842,161 →
Publication: US 2018/0251549
Drug-Conjugates, Conjugation Methods, and Uses Thereof
Application: 15/854,742 →
Publication: US 2018/0243438
Linked Dual Antibodies Conjugated at a Hinge Region
Application: 15/870,830 →
Publication: US 2018/0194859
CELL PENETRATING PEPTIDE INHIBITORS OF p53-MDM2 INTERACTION
Application: 15/880,101 →
Publication: US 2018/0207285
Increased Bioavailability of Transdermally Delivered Agents
Application: 15/890,570 →
Publication: US 2018/0185626
Antigen Binding Proteins that Bind CCR2
Application: 15/925,494 →
Publication: US 2019/0062440
CD38 Antibody Drug Conjugate
Application: 16/013,828 →
Publication: US 2018/0360985
Disulfide Bridging Conjugates
Application: 16/052,406 →
Publication: US 2019/0038764
Antibody Therapeutics That Bind CD38
Application: 16/055,065 →
Publication: US 2019/0048092
Antigen Binding Proteins That Bind Pd-L1
Application: 16/111,995 →
Publication: US 2019/0060451
Formulation of Resiniferatoxin
Application: 16/128,053 →
Publication: US 2019/0076396
Antibody Therapeutics That Bind CD123
Application: 16/135,886 →
Publication: US 2019/0002576
Antibody Therapeutics That Bind Psma
Application: 16/138,944 →
Publication: US 2019/0010250
Strap Component for a Fluid Delivery Apparatus
Patent: 810,604 →
Application: 29/587,921 →
Collet for a Fluid Delivery Apparatus
Patent: 831,198 →
Application: 29/587,922 →
Cartridge for a Fluid Delivery Apparatus
Patent: 836,774 →
Application: 29/587,923 →
Fluid Delivery Apparatus
Patent: 819,197 →
Application: 29/587,924 →
Applicator Device for a Fluid Delivery Apparatus
Patent: 810,927 →
Application: 29/587,926 →
Carrying Case
Patent: 810,421 →
Application: 29/587,927 →
Methods for Lower Dose Pain Treatment Administration of Resinferatoxin
Application: 62/258,349 →
CD38-Directed CAR Constructs
Application: 62/581,466 →
Process for Antigen Receptor Construct Insertion to Transfect Cells
Application: 62/635,702 →
Drug Delivery Method for Regional or Systemic Treatment of the Lymphatic System
Application: 62/678,584 →
Drug Delivery to the Lymphatic System for Regional or Systemic Treatment of Inflammatory Conditions
Application: 62/678,592 →
Drug Delivery to the Lymphatic System for Regional or Systemic Treatment of Cancer
Application: 62/678,601 →
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Name Change Feb 3, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 034880/0674 →
Name Change Feb 3, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 034880/0634 →
Assignment of Assignor's Interest Sep 13, 2018
From: PATTERSON, JAMES T.; KAUFMANN, GUNNAR F.; FU, YANWEN; ZHU, TONG
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 046869/0745 →
Assignment of Assignor's Interest Sep 18, 2018
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 046899/0689 →
Security Interest Nov 7, 2018
From: SORRENTO THERAPEUTICS, INC.; TNK THERAPEUTICS, INC.; CONCORTIS BIOSYSTEMS, CORP.; ARK ANIMAL HEALTH, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 047446/0335 →
Assignment of Assignor's Interest May 9, 2022
From: GASTWIRT, RANDY; ZHOU, HEYUE; GRAY, JOHN DIXON; LU, GUODI
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 059869/0651 →
Security Interest Apr 6, 2023
From: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
To: JMB CAPITAL PARTNERS LENDING, LLC
Reel/Frame 063283/0063 →
Security Interest Jul 31, 2023
From: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
To: SCILEX HOLDING COMPANY
Reel/Frame 064441/0575 →
Release of Security Interest Aug 11, 2023
From: JMB CAPITAL PARTNERS LENDING, LLC
To: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
Reel/Frame 064571/0848 →
Termination and Release of Security Interest in Intellectual Property Sep 21, 2023
From: SCILEX HOLDING COMPANY
To: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
Reel/Frame 065017/0844 →
Assignment of Assignor's Interest May 24, 2024
From: SORRENTO THERAPEUTICS, INC.
To: VIVASOR, INC.
Reel/Frame 067521/0619 →
Assignment of Assignor's Interest May 24, 2024
From: SORRENTO THERAPEUTICS, INC.
To: VIVASOR, INC.
Reel/Frame 067529/0019 →